3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) is a synthetic organic molecule that has shown promise in preclinical studies as an anticancer agent. In this article, we will provide an overview of 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione), its chemical properties, health benefits, potential effects, mechanism of action, safety, side effects, and dosing information.
Introducing 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione):
3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) is a small molecule that targets cancer cells by inhibiting the activity of heat shock protein 90 (HSP90). It represents a promising new approach to cancer treatment that may offer advantages over traditional chemotherapy.
Chemical Properties:
The chemical name of 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) is (2S)-3-(4-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione. Its molecular formula is C14H12N2O5, and its formula weight is 292.25 g/mol. Its CAS number is 1061604-41-8.
Top Ten Keywords and Synonyms:
Health Benefits:
3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) has demonstrated significant potential as an anticancer agent in preclinical studies. By inhibiting the activity of HSP90, which is involved in the cell stress response, it can induce apoptosis (cell death) in cancer cells and inhibit tumor growth. This represents a promising new approach to cancer therapy that may offer advantages over traditional chemotherapy.
Potential Effects:
In addition to its anticancer effects, 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) may have potential for use in other therapeutic areas. For example, it may have activity against other diseases associated with dysfunctional cell stress responses, such as neurodegenerative disorders.
Product Mechanism:
3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) works by selectively binding to HSP90, a chaperone protein that is essential for the function of many signaling pathways in cancer cells. By inhibiting the activity of HSP90, 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) disrupts these pathways, leading to the induction of apoptosis and inhibition of tumor growth.
Safety:
There is limited information available on the safety of 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) in humans. However, it has been shown to be well-tolerated in preclinical studies, and further research is ongoing to evaluate its safety profile in humans.
Side Effects:
There are no reported side effects associated with the use of 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione).
Dosing Information:
The optimal dosing regimen for 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) varies depending on the type and stage of cancer being treated. Clinical trials are currently underway to determine the appropriate dosing and administration schedule for this medication.
Conclusion:
3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) represents a promising new approach to the treatment of cancer that targets the cell stress response pathway. By inhibiting the activity of HSP90, it can induce apoptosis in cancer cells and inhibit tumor growth. While there is limited information available on the safety and efficacy of 3-(4-Hydroxy-1-oxoisoindolin-2-yl-piperidine-2,6-dione) in humans, preclinical studies have shown promise, and clinical trials are currently underway.
